Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13

BACKGROUND: Interleukin-25 (IL-25) is a potent activator of type-2 immune responses. Mucosal inflammation in ulcerative colitis is driven by type-2 cytokines. We have previously shown that a neutralizing anti-IL-25 antibody abrogated airways hyperreactivity in an experimental model of lung allergy....

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Camelo, Ana, Barlow, Jillian L., Drynan, Lesley F., Neill, Daniel R., Ballantyne, Sarah J., Wong, See Heng, Pannell, Richard, Gao, Wei, Wrigley, Keely, Sprenkle, Justin, McKenzie, Andrew N. J.
Format: Artigo
Langue:Inglês
Publié: Springer Japan 2012
Sujets:
Original Article—Alimentary Tract
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3501170/
https://ncbi.nlm.nih.gov/pubmed/22539101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-012-0591-2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires